ResearcherUniversity of Tennessee Health Science CenterNo recent work listed
Anupama Mittal
Matched on ORCID iD 0000-0003-3344-9579; OpenAlex author ID A5040955433. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2013: 1 paper · 2014: 1 paper · 2015: 1 paper
Papers 3
- miRNAs in pancreatic cancer: therapeutic potential, delivery challenges and strategies. First author DOI 10.1016/j.addr.2014.09.006↗
- Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2014.04.053↗
- Self-assembling, amphiphilic polymer-gemcitabine conjugate shows enhanced antitumor efficacy against human pancreatic adenocarcinoma. First author DOI 10.1021/bc400032x↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Deepak Chitkara · 3 shared papers, 2013–2015 · strength 0.19
- Paper miRNAs in pancreatic cancer: therapeutic potential, delivery challenges and strategies. DOI 10.1016/j.addr.2014.09.006↗
- Paper Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer. DOI 10.1016/j.biomaterials.2014.04.053↗
- Paper Self-assembling, amphiphilic polymer-gemcitabine conjugate shows enhanced antitumor efficacy against human pancreatic a… DOI 10.1021/bc400032x↗
- Ram I. Mahato · 3 shared papers, 2013–2015 · strength 0.19
- Paper miRNAs in pancreatic cancer: therapeutic potential, delivery challenges and strategies. DOI 10.1016/j.addr.2014.09.006↗
- Paper Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer. DOI 10.1016/j.biomaterials.2014.04.053↗
- Paper Self-assembling, amphiphilic polymer-gemcitabine conjugate shows enhanced antitumor efficacy against human pancreatic a… DOI 10.1021/bc400032x↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.